S32
Overview
S32 is a venture capital firm investing at the frontiers of technology, healthcare, and life sciences. Founded by Bill Maris, the team has deep experience building iconic companies. Their goal is to accelerate the discovery, development, and distribution of revolutionary technologies that improve the human condition. S32 invests across the entirety of technology, including artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing, computational biology, and biotechnology. The firm has over $2 billion under management and has backed over 100 startups across various software-driven industries, including cybersecurity, quantum and precision medicine, and computational biology. Notable investments include Cohere, Inceptive, Deel, Inworld, Gusto, Phaidra, and BigHat Biosciences. In October 2023, S32 closed its Fund 5, an oversubscribed $525 million fund, to invest in companies advancing software and artificial intelligence to enable new capabilities across markets such as enterprise software, cybersecurity, data infrastructure, gaming, fintech, precision medicine, and computational biology. In February 2024, Dr. Andy Conrad, known for his leadership in technology and advanced data science, joined S32 as a General Partner. Dr. Conrad previously founded and served as the CEO and Executive Chairman of Verily Life Sciences at Alphabet (Google).
Investment Focus
- Focus on software-driven businesses in technology and healthcare sectors
- Investments in companies at various stages, from seed to late stage
- Geographical focus on United States and select international markets
- Interest in industries such as artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing, computational biology, and biotechnology
Portfolio Companies
Reach S32 directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about S32
What sectors does S32 invest in?
S32 invests in Healthcare, Software, FinTech, Artificial Intelligence, Gaming and Life Sciences, and is based in Palo Alto, United States. S32 is listed as a venture capital in the ConnectSafely investor database.
What stage does S32 invest at?
S32 backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 100M.
Which regions does S32 invest in?
S32 invests across United States, United Kingdom, Canada, Germany, Hong Kong and Japan.
Who are the partners at S32?
Team members listed for S32 include Nick Smith (Chief Investor Relations Officer) and Andrew Harrison (CEO & General Partner).
What companies has S32 invested in?
S32's portfolio includes Cohere, Inceptive, Deel, Inworld, Gusto, Phaidra, BigHat Biosciences and Coinbase.
How do I contact S32?
S32's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
